š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691339
This is a study to assess the immune (antibody) response and safety of the ...
Status
Completed
Location
Study Site
Start Date
2012-05
Trial ID
NCT01591837
Treatments Being Tested
The aim of this clinical study is to demonstrate safety and immunogenicity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691326
To evaluate the safety of a single intramuscular (IM) injection of trivalen...
Status
Completed
Location
University Hospital Ghent, Center for Vaccinology, Prof.Dr. G Leroux Roels
Start Date
2012-07
Trial ID
NCT01636102
Treatments Being Tested
The purpose of this study is to evaluate the safety of a single intramuscul...
Status
Completed
Location
Bernhard Nocht Institute
Start Date
2012-07
Trial ID
NCT01640314
Treatments Being Tested
The aim of the study is to demonstrate safety and immunogenicity of the qua...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01712984
Treatments Being Tested
This protocol was designed to evaluate the safety, clinical tolerability an...
Status
Completed
Location
University of Rostock, Department Tropical Medicine and Infectious Diseases
Start Date
2012-07
Trial ID
NCT01640327
Treatments Being Tested
To evaluate the safety of a single intramuscular (IM) injection of trivalen...
Status
Completed
Location
University Hospital Ghent Center for Vaccinology
Start Date
2012-07
Trial ID
NCT01651104
Treatments Being Tested